You have 9 free searches left this month | to do more

apalutamide

Apalutamide is a drug used to treat Prostate Cancer, Prostatic Neoplasms, Prostate Adenocarcinoma, and other conditions. Apalutamide is being actively studied in 47 studies and prior, has been studied in 9.

Top SponsorsTop SitesTop Investigators
Janssen Research & Development, LLCM D Anderson Cancer CenterMichael Schweizer
M.D. Anderson Cancer CenterMemorial Sloan Kettering Cancer CenterRahul Aggarwal
Aragon Pharmaceuticals, Inc.Washington University School of MedicineAlexandra Sokolova, M.D.
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
R
Recruiting
  • Small Cell Neuroendocrine Carcinoma
  • +2 more
  • Apalutamide
  • Cetrelimab
  • San Francisco, California
    University of California, San Francisco
2022-03-21
Mar 21, 2022
U
Terminated
  • Prostate Adenocarcinoma
  • Apalutamide
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2021-12-28
Dec 28, 2021
Z
Not yet recruiting
  • High-Risk and Oligometastatic Prostate Cancer
  • Apalutamide
  • (no location specified)
2021-08-02
Aug 2, 2021
J
Active, not recruiting
  • Prostatic Neoplasms
  • Apalutamide
  • Beijing, China
  • +3 more
2022-03-24
Mar 24, 2022
M
Active, not recruiting
  • Prostate Adenocarcinoma
  • Stage IIB Prostate Cancer AJCC v8
  • Apalutamide
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
2022-02-23
Feb 23, 2022
J
Recruiting
  • Hepatic Impairment
  • Apalutamide
  • Orlando, Florida
  • +2 more
2022-03-24
Mar 24, 2022
W
Active, not recruiting
  • Prostate Cancer Metastatic
  • Apalutamide
  • +3 more
  • Omaha, Nebraska
  • +1 more
2021-08-26
Aug 26, 2021
C
Recruiting
  • Prostate Cancer
  • Shatin, Hong Kong
    Prince of Wales Hospital
2021-08-03
Aug 3, 2021
I
Active, not recruiting
  • Prostate Cancer
  • Sao Paulo, SP, Brazil
    Instituto do Cancer do Estado de Sao Paulo
2021-05-14
May 14, 2021
U
Recruiting
  • Castration Levels of Testosterone
  • +3 more
  • Apalutamide
  • Stereotactic Body Radiation Therapy
  • San Francisco, California
    University of California, San Francisco
2021-08-26
Aug 26, 2021
C
Completed
  • Prostate Cancer
  • Leuprolide acetate
  • +2 more
  • Cleveland, Ohio
    Cleveland Clinic, Case Comprehensive Cancer Center
2021-03-24
Mar 24, 2021
U
Withdrawn
  • Prostatic Neoplasms, Castration-Resistant
  • (no location specified)
2020-11-15
Nov 15, 2020
K
Recruiting
  • Metastatic Castration-sensitive Prostate Cancer
  • Apalutamide
  • Ōsaka-sayama, Osaka, Japan
    Kindai University Hospital
2020-12-06
Dec 6, 2020
J
Active, not recruiting
  • Salivary Gland Neoplasms
  • Apalutamide
  • GnRH Agonist
  • Chuo-Ku, Japan
  • +6 more
2022-03-24
Mar 24, 2022
D
Active, not recruiting
  • Prostate Cancer
  • Apalutamide
  • +3 more
  • La Jolla, California
  • +3 more
2021-09-01
Sep 1, 2021
C
Recruiting
  • Cancer of Prostate
  • Apalutamide
  • +4 more
  • Aalst, Belgium
  • +8 more
2021-08-04
Aug 4, 2021
N
Recruiting
  • Localized Prostate Carcinoma
  • +8 more
  • Apalutamide
  • Quality-of-Life Assessment
  • Tucson, Arizona
  • +4 more
2022-02-19
Feb 19, 2022
M
Completed
  • Prostate Adenocarcinoma
  • +4 more
  • Abiraterone Acetate
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
2021-05-14
May 14, 2021
E
Withdrawn
  • Prostate Cancer
  • Radiation Therapy
  • +3 more
  • (no location specified)
2020-08-13
Aug 13, 2020
D
Active, not recruiting
  • Prostate Cancer
  • San Diego, California
  • +7 more
2022-03-07
Mar 7, 2022
J
Completed
  • Healthy
  • Apalutamide
  • Merksem, Belgium
    Clinical Pharmacology Unit
2020-08-07
Aug 7, 2020
A
Available
  • Prostatic Neoplasms
  • Apalutamide
  • ADT (Standard of Care)
  • Florianopolis, Brazil
  • +19 more
2022-03-28
Mar 28, 2022